Biography:

Andrew Teasdale Ph.D. has 30 years’ experience in the pharmaceutical industry as an analytical chemist and within quality assurance and regulatory roles. In his current role he chairs AstraZeneca’s Impurity Advisory Group. Dr. Teasdale has published a number of papers relating to mutagenic impurities, extractable and leachable, mutagenic impurities and other impurity-related matters. Andrew has also represented EFPIA in ICH Q3C, Q3D and Q3E Expert working groups. He has also advanced a number of key scientific advancements in the control of impurities as the inventor of the purge factor concept and the instigator of the development of the Elemental Impurities database for excipients. With over 50 scientific papers, he has also written 3 books:

• Genotoxic Impurities – Strategies for Identification and Control. Editor A Teasdale. Publisher Wiley. ISBN 978-0-470-49919-1
• ICH Quality Guidelines – An Implementation Guide. Editors A Teasdale, D Elder, R W Nims. Publisher Wiley. ISBN 978-1-118-97111-6.
• Mutagenic Impurities – Strategies for Identification and Control Second Edition. Editor A Teasdale. Publisher Wiley. ISBN 978-1-119-55121-8